SEC Form 4 · accession 0001179110-16-030822
Assertio Therapeutics, Inc · ASRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James P Fogarty
Director
Period of report
Oct 17, 2016
Accepted (ET)
Oct 19, 2016 · 5:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005201
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1 | $23.83 | Oct 17, 2016 | A | 18,485 | A | — | Oct 17, 2026 | Common Stock | 18,485 | 18,485 | D |
Explanation of responses
- F1These stock options are exercisable in 36 equal monthly installments.